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Abstract 
BACKGROUND: The incidence of diabetes and its complications has risen since the last decades, and it has 
been predicted that the prevalence of diabetes will be double in the coming year. Chronic hyperglycemia marked 
as elevated advanced glycation end products plays an important role in complications of diabetes. Basil leaves 
(Ocimum basilicum) originating from India and commonly found in Southeast Asia, is widely used empirically to 
decrease the blood sugar in diabetic patients. 
AIM: The purpose of the study was to investigate the effect of extract ethanol of Basil leaves in diabetic rats. 
METHODS: This is an experimental study; Streptozotocin was used to induce type 2 diabetic rats. Thirty Wistar 
male rats were divided into six groups (normal group, group treated with metformin 45 mg/kg body weight, group 
treated with Basil leaves 100 mg/kg body weight, 200 mg/kg body weight, 400 mg/kg body weight, control diabetic 
group). The blood glucose level was measured before induction and after treatment at week 1 and 4. Advanced 
glycation end products were measured in all groups at week 4. 
RESULTS: Extract ethanol of basil leaves 100, 200, 400 mg/body weight all showed significant lowering blood 
glucose level (p < 0.001) compared to diabetic group without treatment, but did not show superior to metformin 
group (p = 0.17), advanced glycation end products did not show statistical significance between group with normal 
rats and group of diabetic rats treated with basil leaves 100 mg/kg, 200 mg/kg, 400 mg/kg (p = 0.12, p = 0.33, p = 
0.26). 
CONCLUSION: Extract ethanol of basil leaves showed good results in lowering blood glucose and advanced 
glycation end products in diabetic rats. 
 
 
 
 
 
 
 
Introduction 
 
Diabetes Mellitus (DM) is a chronic metabolic 
disease manifested with hyperglycemia caused by 
insulin deficiency or resistance. Prolonged elevation of 
the blood glucose level will cause macro and 
microvascular complications that resulted in damage 
of various organs of the body. More than eighty per 
cent of these conditions were found in low- or middle-
income countries [1]. It is estimated that in 2030, in 
every ten adults one person will get diabetes mellitus 
(DM) [2]. Chronic hyperglycemia may induce glycation 
of various plasma proteins, and collagen [3] thus 
advanced glycation end-products (AGEs) are largely 
produced and accumulated in various tissues and 
blood circulation [4]. This result of protein formation 
through non-enzymatic processes caused by high 
blood sugar levels are thought to alter the hemostatic 
system, activated coagulation system and generation 
of oxygen free radicals. Advanced glycation is one of 
the major causes of diabetic complications [5], [6]. 
Control diets, exercise and medicine, have been the 
mainstay treatments of diabetes [7], [8], [9]. Most of 
the people in Indonesia still used traditional medicine 
empirically to treat diabetes, like Poguntano leaves 
[10] as Indonesia is a country of plenty of medicinal 
plants. Basil leaves (Ocimum basilicum) from 
family Lamiaceae (mints) known as the king of herbs 
or "royal herb" originating from India and commonly 
found in Southeast Asia, is widely used as a culinary 
ingredient [11], [12]. 
Empirically, it was used widely to decrease 
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blood sugar in diabetic patients.
 
Basil leaves were 
reported to have antihyperglycemic and liver 
protective effects as it stimulates the release of insulin 
from the pancreas, inhibit the glucose production in 
the liver and increased glycogen synthesis [13], [14].  
This study aimed to study the effect of basil 
leaves on blood glucose level and AGE in diabetic 
rats.  
 
 
Methods 
 
This is an experimental study using 
Streptozotocin (STZ) in a dose of 40 mg/body weight 
injected intraperitoneal to induce type 2 diabetic rats. 
Thirty Wistar male rats weighed 150-200 grams were 
divided into six groups (normal group, group treated 
with metformin in a dose of 45 mg/kg body weight, 
group treated with basil leaves 100 mg/kg body 
weight, 200 mg/kg body weight, 400 mg/kg body 
weight, control diabetic group) for four weeks. Blood 
glucose levels were measured before starting the 
experiment; after the induction, blood glucose levels 
were measured in all groups at week 1, 4 and AGE 
level were measured in all groups at week 4. 
This study will be analysed using SPSS V20 
with One Way ANOVA. 
 
Preparation of basil extract  
Extraction was carried out by maceration 
using 96% ethanol as solvent standardisation of 
extracts including the determination of water content, 
levels of water-soluble and ethanol extracts, total ash 
content, insoluble acid and chromatogram profiles 
[15].  
 
Laboratory Assay 
Blood Glucose was measured using 
spectrophotometry, and AGE using sandwich Elisa 
with a double antibody. 
 
 
Results 
 
One way ANOVA was used to analyse the 
blood glucose levels at week 4 within groups, and it 
showed statistically significant (p = 0.0). Post hoc was 
used to analysed further and found out that the blood 
glucose level was statistically significant differences 
within the diabetic and treatment groups (p = 0.00) but 
did not show the statistical difference (p = 1) within 
treatment groups (metformin and basil groups). 
Table 1: Blood Glucose level before induction of Streptozocin 
in all groups 
 Group A Group B 
 
Group C 
 
Group D 
 
Group E 
 
Group F 
 
Blood Glucose level 
(mg/dl) 
78 ± 2 79.3 ± 1.5 78 ± 2 80 ± 2 79.3 ± 2 81. 3 ±1.5 
Note: Group A: normal control, Group B: Diabetic Control, Group C: a group treated with 
metformin, Group D: group treated with basil 100 mg, Group E: a group treated with basil 
200 mg, Group F: a group treated with basil 400 mg. 
 
Advanced glycation end products showed 
statistical significant within diabetic control group and 
group treated either with metformin or basil leaves (p 
= 0.01), but did not showed statistical significance 
between group with normal rats and group of diabetic 
rats treated with basil leaves extracts 100mg/kg, 200 
mg/kg, 400 mg/kg (p = 0.12, p = 0.33, p = 0.26). 
Table 2: Data of blood glucose level and AGE of experimental 
rats 
 Group A Group B 
 
Group C 
 
Group D 
 
Group E 
 
Group F 
 
T1 (mg/dl) 80 ± 1 501 ± 6.1 553 ± 5 473 ± 2.5 531 ± 4.1 525 ± 7.8 
T4 (mg/dl) 80 ± 1.5 495 ± 4.6 92 ± 4 131 ± 6.4 123 ± 3 107 ± 3 
AGE (ng/ml) 8.5 ± 1.3 5.6 ± 1.4 17 ± 1.0 4.6 ± 1.8 5.5 ± 1.8 5.2 ± 1.3 
Notes: T1: blood glucose level after 1 week STZ injection; T4: blood glucose level week 4. 
  
 
 
Discussion 
 
Basil leaves extract showed statistical 
significant lowering blood glucose between the 
diabetic control group and the group treated with 
metformin or basil leaves either in 100, 200, 400 
mg/kg body weights (p = 0.0), but did not show a 
statistical difference within the treatment group (p = 1). 
This means that either metformin or basil leaves can 
be used for lowering blood glucose, and one is not 
inferior to the other; this has been reported by 
Eddouks M and Kumar S that basil leaves have the 
ability as anti-diabetic agents and improve the insulin 
sensitivity [16], [17].  
Advanced glycation end products showed a 
significant difference between the diabetic control 
group and group treated either with metformin or basil 
leaves; these results showed that the Basil leaves 
could also be used to treat the chronic hyperglycemic 
effect of diabetes, one of the most important issues in 
diabetes.  
In the basil treatment group, we do not find 
any inferior effect in lowering blood glucose level in 
the three groups (100 mg, 200 mg, 400 mg/kg body 
weights). 
In conclusion, extract ethanol of basil leaves 
showed good results in lowering blood glucose and 
advanced glycation end products in diabetic rats. 
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